Sartorius has acquired ViroCyt Inc., a U.S. start-up based in Broomfield, CO working in the field of rapid virus quantification, in a transaction valuing ViroCyt at approximately $16 million. ViroCyt is expected to achieve double-digit growth and generate more than $3 million sales in 2016.   ViroCyt’s main clients include pharma and biopharma R&D labs, vaccine manufacturers, as well as academia. The company’s automated platform, which integrates instruments, software and reagents, deliver...